After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
Globus Medical Inc is listed on the NYSE as a member of the Healthcare sector and is a part of the Medical Devices industry. The current market capitalization of Globus Medical Inc is $9.76B. A total of 0.64 million shares were traded on the day, compared to an average of 958.63K shares.
In the most recent transaction, Norwalk Leslie V sold 1,000 shares of GMED for 70.00 per share on Jul 11 ’24. After the transaction, the Director now owns 16,419 company shares. In a previous transaction on May 10 ’24, Lemaitre Dan sold 63,300 shares at 64.61 per share. GMED shares that Director owns now total 0.
Among the insiders who sold shares, Davidar David D disposed of 20,000 shares on May 08 ’24 at a per-share price of $65.00. This resulted in the Director holding 566,275 shares of GMED after the transaction. In another insider transaction, Norwalk Leslie V sold 10,590 shares at $51.99 per share on Mar 15 ’24. Company shares held by the Director now total 17,419.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, GMED has a high of $74.21 and a low of $43.38.
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. GMED’s latest balance sheet shows that the firm has $443.45M in Cash & Short Term Investments as of fiscal 2021. Its Book Value Per Share was $29.38, while its Total Shareholder’s Equity was $1.74B.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for GMED is Buy with a score of 4.07.
